The HIV epidemic in England, France, Germany, Spain and Italy (Europe5) today is unrecognisable from a few decades ago. The number of people dying from HIV-related illnesses has declined, while more and more people are on anti-retroviral therapy (ART), and virally supressed. Their life expectancy is close to that of the general population and they cannot pass the infection to others.
However, the epidemic has not ended, it has only changed. New and continuing challenges threaten the HIV response. In order to tackle these, policies across Europe5 must evolve.
In this report, compiled by KPMG in the UK, a group of experts in HIV (Steering Group) have assessed HIV-related policies from the Europe5. This report looked at the HIV care continuum of awareness; prevention; testing and screening; HIV-specific clinical treatment; as well as long term holistic health. They identified areas of strength, along with areas to develop, and made a set of recommendations to help improve the lives of those living with and at risk of HIV.
To drive improvements in the lives of those with, or at risk of HIV, the Steering Group put forward a number of recommendations:
To drive improvements in the lives of those with, or at risk of HIV, the Steering Group put forward a number of recommendations:
To drive improvements in the lives of those with, or at risk of HIV, the Steering Group put forward a number of recommendations:
To drive improvements in the lives of those with, or at risk of HIV, in Germany, the Steering Group put forward a number of recommendations:
To drive greater improvements in the lives of those with or at risk of HIV, the steering group put forward a number of recommendations:
Follow the links to view the complete reports in English or your national language.
This report has been commissioned and paid for by Gilead Sciences Europe Ltd (Gilead).
The reports were compiled by KPMG LLP UK (KPMG in the UK) and guided throughout by an independent Steering Group comprising of policy, clinical and patient experts in HIV.
The Steering Group had editorial control of the report.
If you have any questions around the content of these reports please contact Laura Mace.